Middle East Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Country 2024-2032

Middle East Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A19277
Buy Now

Market Overview:

Middle East cancer diagnostics market size is projected to exhibit a growth rate (CAGR) of 7.65% during 2024-2032. The growing prevalence of cancer among the masses, rising construction of various hospitals and cancer research centers to provide quality healthcare services to patients, and increasing integration of cutting-edge technologies represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 7.65%


Cancer diagnostics refers to the methods and tools used to detect, classify, and monitor cancer. It involves analyzing biological samples or imaging studies to identify abnormal cells or tumors. It employs various imaging modalities, including X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, to visualize tumors and assess their size, location, and involvement with surrounding tissues. It involves the removal and examination of a small tissue sample to determine if cancer cells are present. It consists of blood tests, such as tumor markers and complete blood count (CBC), providing valuable information about the presence of cancer cells, the response of the body to cancer, and overall health. It employs various molecular techniques, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and deoxyribonucleic acid (DNA) sequencing, to analyze the genetic and molecular characteristics of cancer cells and assist in identifying specific mutations and guiding targeted therapies. It allows for timely intervention, increasing the chances of successful treatment and improved survival rates. Cancer diagnostics contribute to the era of precision medicine by identifying specific molecular and genetic characteristics of tumors, enabling targeted therapies tailored to individual patients. It also helps in reducing unnecessary treatments and minimizing side effects, thereby enhancing the overall quality of life for cancer patients.

Middle East Cancer Diagnostics Market Trends:

At present, the increasing prevalence of cancer among the masses due to the adoption of unhealthy lifestyles and excessive consumption of alcohol represents one of the crucial factors impelling the growth of the market in the Middle East. Besides this, the rising integration of cutting-edge technologies, such as next-generation sequencing (NGS), liquid biopsy, and artificial intelligence (AI), which enable the comprehensive analysis of genomic alterations, allowing for a more precise and personalized approach to cancer diagnosis and treatment is contributing to the market growth in the region. In addition, the growing demand for non-invasive methods for detecting circulating tumor DNA, ribonucleic acid (RNA), and proteins in the blood, providing valuable insights into tumor dynamics and facilitating early cancer detection, is offering a favorable market outlook.  Apart from this, governing agencies and healthcare organizations in the region are increasingly investing in screening initiatives to detect cancer at its earliest stages when treatment options are more effective. This emphasis on early detection improves survival rates and reduces the overall cost of cancer treatment by minimizing the need for extensive and costly interventions at later stages of the disease. Additionally, molecular diagnostic techniques, such as fluorescence in situ hybridization (FISH), enable the identification of specific genetic and molecular markers associated with various cancers. This molecular-level precision allows for more accurate diagnosis, prognosis, and treatment selection. Moreover, the increasing construction of various hospitals and cancer research centers to provide quality healthcare services to patients is bolstering the market growth in the region.

Middle East Cancer Diagnostics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Product Insights:

  • Consumables
    • Antibodies
    • Kits and Reagents
    • Probes
    • Others
  • Instruments
    • Pathology-Based Instruments
    • Imaging Instruments
    • Biopsy Instruments
       

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables (antibodies, kits and reagents, probes, and others) and instruments (pathology-based instruments, imaging instruments, and biopsy instruments).

Technology Insights:

  • IVD Testing
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization (ISH)
    • Immunohistochemistry (IHC)
    • Next-Generation Sequencing (NGS)
    • Microarrays
    • Flow Cytometry
    • Immunoassays
    • Others
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Mammography
    • Ultrasound
  • Biopsy Technique
     

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes IVD testing (polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next-generation sequencing (NGS), microarrays, flow cytometry, immunoassays, and others), imaging (magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, and ultrasound), and biopsy technique.

Application Insights:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the application. This includes breast cancer, lung cancer, colorectal cancer, melanoma, and others.

End User Insights:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
     

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic laboratories, and others.

Country Insights:

  • Saudi Arabia
  • Turkey
  • Israel
  • United Arab Emirates
  • Iran
  • Iraq
  • Qatar
  • Kuwait
  • Oman
  • Jordan
  • Bahrain
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Saudi Arabia, Turkey, Israel, United Arab Emirates, Iran, Iraq, Qatar, Kuwait, Oman, Jordan, Bahrain, and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Middle East Cancer Diagnostics Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product
  • Technology
  • Application
  • End User
  • Country 
Products Covered
  • Consumables: Antibodies, Kits and Reagents, Probes, Others
  • Instruments: Pathology-Based Instruments, Imaging Instruments, Biopsy Instruments
Technologies Covered
  • IVD Testing: Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Microarrays, Flow Cytometry, Immunoassays, Others
  • Imaging: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Mammography, Ultrasound
  • Biopsy Technique
Applications Covered Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others
End Users Covered Hospitals and Clinics, Diagnostic Laboratories, Others
Countries Covered Saudi Arabia, Turkey, Israel, United Arab Emirates, Iran, Iraq, Qatar, Kuwait, Oman, Jordan, Bahrain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Middle East cancer diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Middle East cancer diagnostics market?
  • What is the breakup of the Middle East cancer diagnostics market on the basis of product?
  • What is the breakup of the Middle East cancer diagnostics market on the basis of technology?
  • What is the breakup of the Middle East cancer diagnostics market on the basis of application?
  • What is the breakup of the Middle East cancer diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Middle East cancer diagnostics market? 
  • What are the key driving factors and challenges in the Middle East cancer diagnostics?
  • What is the structure of the Middle East cancer diagnostics market and who are the key players?
  • What is the degree of competition in the Middle East cancer diagnostics market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Middle East cancer diagnostics market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Middle East cancer diagnostics market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Middle East cancer diagnostics industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Middle East Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More